Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxart, Inc

0.3365
-0.0427-11.26%
Post-market: 0.35700.0205+6.09%19:59 EDT
Volume:2.96M
Turnover:1.04M
Market Cap:76.70M
PE:-1.02
High:0.3967
Open:0.3820
Low:0.3355
Close:0.3792
Loading ...

Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues

Reuters
·
03 Apr

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

Reuters
·
31 Mar

BRIEF-Vaxart Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
27 Mar

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
27 Mar

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
27 Mar

B. Riley Cuts Price Target on Vaxart to $2 From $2.50, Keeps Buy Rating

MT Newswires Live
·
27 Mar

Vaxart Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
22 Mar

BRIEF-Vaxart Inc to offer up to $50 mln of common stock

Reuters
·
22 Mar

Q4 2024 Vaxart Inc Earnings Call

Thomson Reuters StreetEvents
·
21 Mar

Vaxart Inc (VXRT) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Adjustments ...

GuruFocus.com
·
21 Mar

VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
21 Mar

Vaxart Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Mar

BRIEF-Vaxart Provides Business Update And Reports Full Year 2024 Financial Results

Reuters
·
21 Mar

Vaxart FY 2024 GAAP EPS $(0.33) Beats $(0.39) Estimate, Sales $28.700M Beat $16.550M Estimate

Benzinga
·
21 Mar

Vaxart Inc - Implements 10% Workforce Reduction

THOMSON REUTERS
·
21 Mar

Vaxart Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
19 Mar

Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20

GlobeNewswire
·
13 Mar

Vaxart Announces Clinical Trial Initiation of Norovirus Oral Pill Vaccine Candidate

GlobeNewswire
·
11 Mar

Vaxart Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
10 Mar

Vaxart announces norovirus vaccine candidate trial data published

TIPRANKS
·
06 Mar